Roquefort Therapeutics (ROQ)

Sector:

Alternative Investment Instruments

 1.70p
   
  • Change Today:
      0.000p
  • 52 Week High: 6.25
  • 52 Week Low: 1.55
  • Currency: UK Pounds
  • Shares Issued: 154.98m
  • Volume: 573,383
  • Market Cap: £2.63m
  • Beta: 0.06

ROQ Overview

We established Roquefort Therapeutics plc to acquire businesses focused on early-stage opportunities in the medical biotechnology sector with the aim of generating optimal returns for both the target businesses and our shareholders. The investment strategy of the Company is to provide Shareholders with an attractive total return achieved primarily through capital appreciation. The Directors believe that there are numerous investment opportunities within both private and public businesses in the medical biotech sector in the United Kingdom, Continental Europe and Australia.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 0.5  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

ROQ Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 n/a (0.92) (3.71)p n/a n/a n/a n/a 0.0%
31-Dec-22 n/a (1.63) (1.56)p n/a n/a n/a n/a 0.0%
31-Dec-23 0.20 (1.93) (1.35)p n/a n/a n/a n/a 0.0%
31-Dec-24 n/a (1.21) (0.75)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

ROQ Company Announcements

Annual Report & Financial Statements - 31 Dec 2024 30-Apr-2025 07:00 RNS
Private Placing and Conversion of CLNs 14-Mar-2025 07:00 RNS
Board Changes 10-Mar-2025 07:30 RNS

ROQ ShareCast News

No recent information was found.

Latest ROQ Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

ROQ Market Data

Currency UK Pounds
Share Price 1.70p
Change Today 0.000p
% Change 0.00 %
52 Week High 6.25
52 Week Low 1.55
Volume 573,383
Shares Issued 154.98m
Market Cap £2.63m
Beta 0.06

ROQ Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
33.94% above the market average33.94% above the market average33.94% above the market average33.94% above the market average33.94% above the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average
Price Trend
90.9% below the market average90.9% below the market average90.9% below the market average90.9% below the market average90.9% below the market average
89.66% below the sector average89.66% below the sector average89.66% below the sector average89.66% below the sector average89.66% below the sector average
Income Not Available
Growth Not Available

ROQ Dividends

No dividends found

Trades for 02-May-2025

Time Volume / Share Price
13:58 114,744 @ 1.73p
12:19 995 @ 1.73p
12:10 22,646 @ 1.74p
10:05 114,354 @ 1.74p
09:15 104,000 @ 1.61p

Top of Page